Introduction: Cervical cancer is one of the leading causes of morbidity and mortality among women in Brazil, especially in regions with lower socioeconomic development. Although this condition is largely preventable through regular cytopathological screening (Papanicolaou test), inequalities in access to preventive services persist. Thus, the Municipal Human Development Index (MHDI), which encompasses income, education, and longevity indicators, is a useful tool to identify how structural factors influence health outcomes. In this context, understanding the association between MHDI and health indicators related to cervical cancer can provide important insights for formulating more effective and equitable public policies. Objectives: To analyze the relationship between the Municipal Human Development Index (MHDI) and indicators of detection and mortality from cervical cancer in the municipalities of the state of Pará, Brazil, during the period from 2019 to 2023. Methods: This is a descriptive study with a quantitative approach, based on secondary data obtained from the Tabnet system of the Ambulatory Information System (SIA/SUS) and the Mortality Information System (SIM). Municipalities in Pará with complete data on the number of cytopathological exams performed, number of deaths due to cervical cancer, and respective MHDI values—extracted from the Atlas of Human Development in Brazil—were included. Statistical analysis was performed using Microsoft Excel software, employing Pearson’s correlation coefficient (CORREL function) to evaluate the association between MHDI and the selected health indicators. Results: The correlation between MHDI and the number of cytopathological exams performed was analyzed in 143 municipalities with complete data, resulting in a coefficient of 0.24, indicating a weak positive correlation. It was observed that municipalities with higher MHDI performed an average of approximately 3,200 exams, while those with lower MHDI recorded fewer than 1,000 exams, evidencing inequality in preventive coverage. Regarding mortality, the analysis included 137 municipalities and found a correlation coefficient of 0.42, indicating a moderate positive correlation. This result may reflect a greater capacity for death registration in more developed municipalities but also suggests that, despite better structural conditions, barriers to effective screening and timely treatment persist, contributing to the maintenance of high mortality rates. Conclusion: The results demonstrate that human development influences, albeit unevenly, the indicators of prevention and mortality due to cervical cancer. The presence of positive correlations with MHDI reinforces the importance of public policies aimed at health equity, with strategies that expand access to screening, diagnosis, and treatment services, especially in municipalities with lower socioeconomic development. Thus, overcoming regional inequalities is essential to reduce morbidity and mortality from this disease and guarantee the right to health for women in Pará.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
